These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 28631243)

  • 1. Amyloid plaques beyond Aβ: a survey of the diverse modulators of amyloid aggregation.
    Stewart KL; Radford SE
    Biophys Rev; 2017 Aug; 9(4):405-419. PubMed ID: 28631243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of β-Amyloid Fibril Formation in Alzheimer's Disease by Microglia and Infection.
    Brown MR; Radford SE; Hewitt EW
    Front Mol Neurosci; 2020; 13():609073. PubMed ID: 33324164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
    Savelieff MG; DeToma AS; Derrick JS; Lim MH
    Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
    Nguyen P; Derreumaux P
    Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.
    Ha C; Ryu J; Park CB
    Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical imaging of evolving amyloid plaque pathology and associated Aβ peptide aggregation in a transgenic mouse model of Alzheimer's disease.
    Michno W; Wehrli P; Meier SR; Sehlin D; Syvänen S; Zetterberg H; Blennow K; Hanrieder J
    J Neurochem; 2020 Mar; 152(5):602-616. PubMed ID: 31605538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid membranes catalyse the fibril formation of the amyloid-β (1-42) peptide through lipid-fibril interactions that reinforce secondary pathways.
    Lindberg DJ; Wesén E; Björkeroth J; Rocha S; Esbjörner EK
    Biochim Biophys Acta Biomembr; 2017 Oct; 1859(10):1921-1929. PubMed ID: 28564579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of different salt ions on the propensity of aggregation and on the structure of Alzheimer's abeta(1-40) amyloid fibrils.
    Klement K; Wieligmann K; Meinhardt J; Hortschansky P; Richter W; Fändrich M
    J Mol Biol; 2007 Nov; 373(5):1321-33. PubMed ID: 17905305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease and cigarette smoke components: effects of nicotine, PAHs, and Cd(II), Cr(III), Pb(II), Pb(IV) ions on amyloid-β peptide aggregation.
    Wallin C; Sholts SB; Österlund N; Luo J; Jarvet J; Roos PM; Ilag L; Gräslund A; Wärmländer SKTS
    Sci Rep; 2017 Oct; 7(1):14423. PubMed ID: 29089568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The binding of resveratrol to monomer and fibril amyloid beta.
    Ge JF; Qiao JP; Qi CC; Wang CW; Zhou JN
    Neurochem Int; 2012 Dec; 61(7):1192-201. PubMed ID: 22981725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein.
    Harper JD; Lieber CM; Lansbury PT
    Chem Biol; 1997 Dec; 4(12):951-9. PubMed ID: 9427660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
    Pinheiro L; Faustino C
    Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
    Drew SC; Barnham KJ
    Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two types of Alzheimer's beta-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation.
    Bokvist M; Lindström F; Watts A; Gröbner G
    J Mol Biol; 2004 Jan; 335(4):1039-49. PubMed ID: 14698298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S14G-humanin inhibits Aβ1-42 fibril formation, disaggregates preformed fibrils, and protects against Aβ-induced cytotoxicity in vitro.
    Zhang W; Du Y; Bai M; Xi Y; Li Z; Miao J
    J Pept Sci; 2013 Mar; 19(3):159-65. PubMed ID: 23349038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Insights into the Spontaneous Human Alzheimer's Disease-Like Model Octodon degus: Unraveling Amyloid-β Peptide Aggregation and Age-Related Amyloid Pathology.
    Cisternas P; Zolezzi JM; Lindsay C; Rivera DS; Martinez A; Bozinovic F; Inestrosa NC
    J Alzheimers Dis; 2018; 66(3):1145-1163. PubMed ID: 30412496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
    Tomiyama T
    Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils.
    Alvarez A; Opazo C; Alarcón R; Garrido J; Inestrosa NC
    J Mol Biol; 1997 Sep; 272(3):348-61. PubMed ID: 9325095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.